The immunosuppressant FK506 prolongs transgene expression in brain following adenovirus-mediated gene transfer

NeuroReport

Volumn 8, Issue 9-10, 1997, Pages 2111-2115

  Durham, Heather D ^a   Alonso Vanegas, Mario A ^a   Sadikot, Abbas F ^a   Zhu, Lixia ^a   Lochmüller, Hanns ^c   Massie, Bernard ^b   Nalbantoglu, Josephine ^a   Karpati, George ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Adenovirus; Brain; FK506; Gene transfer; Immunosuppression; Striatum; Viral vector

Indexed keywords

BETA GALACTOSIDASE; DRUG VEHICLE; IMMUNOSUPPRESSIVE AGENT; SODIUM CHLORIDE; TACROLIMUS; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSFER; IMMUNOSUPPRESSIVE TREATMENT; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; STEREOTAXIS; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENE; VIRUS RECOMBINANT;

EID: 0030878094     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199707070-00005     Document Type: Article

References (26)

1. Karpati G, Lochmüller H, Nalbantoglu J and Durham H. Trends Neurosci 19, 49-54 (1995).
2. Byrnes AP, Rusby JE, Wood MJA and Charlton HM. Neuroscience 66, 1015-1024 (1995).
3. Byrnes AP, MacLaren RE and Charlton HM. J Neurosci 16, 3045-3055 (1996).
4. Durham HD, Lochmüller H, Jani A et al. Exp Neurol 140, 14-20 (1996).
5. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH et al. Gene Ther 1, 395-402 (1994).
6. Acsadi G, Lochmüller H, Jani A et al. Hum Gene Ther 7, 129-140 (1996).
7. Yang Y, Li Q, Ertl HCJ and Wilson JM. J Virol 69, 2004-2015 (1995).
8. Yang Y, Nunes FA, Berencsi K et al. Proc Natl Acad Sci USA 91, 4407-4411 (1994).
9. Wood MJA and Charlton HM. Trends Neurosci 19, 497-501 (1996).
10. Geddes BJ, Harding TC, Hughes DS et al. Endocrinology 137, 5166-5169 (1996).
11. Kajiwara K, Byrnes AP, Charlton HM et al. Human Gene Ther 8, 253-265 (1997).
12. Acsadi G, Jani A, Massie B et al. Hum Mol Genet 3, 579-584 (1994).
13. Lochmüller H, Petrof BJ, Pari G et al. Gene Ther 3, 706-716 (1996).
14. Vilquin JT, Guėrette B, Kinoshita I et al. Hum Gene Ther 6, 1391-1401 (1995).
15. Lochmüller H, Petrof BJ, Allen C et al. Biochem Biophys Res Commun 213, 569-574 (1995).
16. Caillaud C, Akli S, Vigne E et al. Eur J Neurosci 5, 1287-1291 (1993).
17. Marks AR. Physiol Rev 76, 631-649 (1996).
18. Snyder SH and Sabatini DM. Nature Med 1, 32-37 (1995).
19. Dawson TM, Steiner JP, Dawson VL et al. Proc Natl Acad Sci USA 90, 9808-9812 (1993).
20. Sharky J and Butcher SP. Nature 371, 336-339 (1994).
21. Lyons WE, George EB, Dawson TM et al. Proc Natl Acad Sci USA 91, 3191-3195 (1994).
22. Gold BG, Katoh K and Storm-Dickerson T. J Neurosci 15, 7509-7516 (1995).
23. Lyons WE, Steiner JP, Snyder SH and Dawson TM. J Neurosci 15, 2985-2994 (1995).
24. Dawson TM. Ann Neurol 40, 559-560 (1996).
25. Bronster DJ, Yonover P, Stein J et al. Transplantation 59, 1066-1068 (1995).
26. Torri N, Kamishita T, Otsu Y and Tsumoto T. Neurosci Lett 185, 1-4 (1995).